BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 17393538)

  • 21. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
    Manuelidis L
    J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroinvasion in sheep transmissible spongiform encephalopathies: the role of the haematogenous route.
    Sisó S; Jeffrey M; González L
    Neuropathol Appl Neurobiol; 2009 Jun; 35(3):232-46. PubMed ID: 19473292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of prion disease progression: a chemical reaction network approach.
    Méndez JM; Femat R
    IET Syst Biol; 2011 Nov; 5(6):347-52. PubMed ID: 22129030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the role of dendritic cells in prion transfer to primary neurons.
    Langevin C; Gousset K; Costanzo M; Richard-Le Goff O; Zurzolo C
    Biochem J; 2010 Oct; 431(2):189-98. PubMed ID: 20670217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germinal center B cells are dispensable in prion transport and neuroinvasion.
    Heikenwalder M; Federau C; Boehmer Lv; Schwarz P; Wagner M; Zeller N; Haybaeck J; Prinz M; Becher B; Aguzzi A
    J Neuroimmunol; 2007 Dec; 192(1-2):113-23. PubMed ID: 17964667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.
    Korth C; Kaneko K; Groth D; Heye N; Telling G; Mastrianni J; Parchi P; Gambetti P; Will R; Ironside J; Heinrich C; Tremblay P; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4784-9. PubMed ID: 12684540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transmissible spongiform encephalopathies (prion diseases)--molecular principles and in vitro models].
    Kretzschmar H
    Wien Med Wochenschr; 1998; 148(4):67-73. PubMed ID: 9611345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion diseases and the immune system.
    Aucouturier P; Frangione B; Wisniewski T
    Ann Med Interne (Paris); 1999 Feb; 150(2):75-8. PubMed ID: 10392254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of prion pathogenesis.
    Aguzzi A; Sigurdson C; Heikenwaelder M
    Annu Rev Pathol; 2008; 3():11-40. PubMed ID: 18233951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of molecular target based-therapy for prion diseases].
    Sakasegawa Y; Doh-ura K
    Brain Nerve; 2007 Apr; 59(4):405-14. PubMed ID: 17447527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the natural variability of prion diseases.
    Geissen M; Krasemann S; Matschke J; Glatzel M
    Vaccine; 2007 Jul; 25(30):5631-6. PubMed ID: 17391814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cells and prions: a license to replicate.
    Nuvolone M; Aguzzi A; Heikenwalder M
    FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion proteins: physiological functions and role in neurological disorders.
    Hu W; Kieseier B; Frohman E; Eagar TN; Rosenberg RN; Hartung HP; Stüve O
    J Neurol Sci; 2008 Jan; 264(1-2):1-8. PubMed ID: 17707411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prion diseases: what is the role of dendritic cells in the pathogenesis of transmissible prion diseases?].
    Bachy V; Aucouturier P
    Med Sci (Paris); 2010; 26(6-7):615-20. PubMed ID: 20619164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nature and physicochemical and biological properties of non conventional transmissible agents or prions: consequences for public health].
    Dormont D
    Pathol Biol (Paris); 1995 Feb; 43(2):124-36. PubMed ID: 7777382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prions and prion diseases: fundamentals and mechanistic details.
    Ryou C
    J Microbiol Biotechnol; 2007 Jul; 17(7):1059-70. PubMed ID: 18051314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular pathogenesis in prion diseases.
    Crozet C; Beranger F; Lehmann S
    Vet Res; 2008; 39(4):44. PubMed ID: 18413130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion infections, blood and transfusions.
    Aguzzi A; Glatzel M
    Nat Clin Pract Neurol; 2006 Jun; 2(6):321-9. PubMed ID: 16932576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.